| Title : COX-2\/sEH Dual Inhibitor PTUPB Alleviates CCl (4) -Induced Liver Fibrosis and Portal Hypertension - Zhao_2021_Front.Med.(Lausanne)_8_761517 |
| Author(s) : Zhao Z , Zhang C , Lin J , Zheng L , Li H , Qi X , Huo H , Lou X , Hammock BD , Hwang SH , Bao Y , Luo M |
| Ref : Front Med (Lausanne) , 8 :761517 , 2021 |
| Abstract : Zhao_2021_Front.Med.(Lausanne)_8_761517 |
| ESTHER : Zhao_2021_Front.Med.(Lausanne)_8_761517 |
| PubMedSearch : Zhao_2021_Front.Med.(Lausanne)_8_761517 |
| PubMedID: 35004731 |
Zhao Z, Zhang C, Lin J, Zheng L, Li H, Qi X, Huo H, Lou X, Hammock BD, Hwang SH, Bao Y, Luo M (2021)
COX-2\/sEH Dual Inhibitor PTUPB Alleviates CCl (4) -Induced Liver Fibrosis and Portal Hypertension
Front Med (Lausanne)
8 :761517
Zhao Z, Zhang C, Lin J, Zheng L, Li H, Qi X, Huo H, Lou X, Hammock BD, Hwang SH, Bao Y, Luo M (2021)
Front Med (Lausanne)
8 :761517